Overview of Our Approach

Toxicities from immune checkpoint inhibitors remain poorly understood. Understanding why they occur in certain patients, how to best treat them, and optimizing care in health care systems are key unanswered questions. We have brought together physicians and scientists from a broad range of specialties to address these questions using clinical, translational, and basic science research. 



V-POINT's success hinges on close collaboration among physicians and scientists, as well as experts across multiple subspecialties. Toxicities from immunotherapies affect every organ system, and we look forward to bringing together experts from every disease group for comprehensive patient care.

Research Opportunities

The V-POINT program is interested in recruiting talented physician-scientists and scientists from different organ disciplines. If interested, please contact us. Send inquiries to Kathryn Mashburn at


Additional Resources